ArticleFrontiers in adolescent medicine2025
Acute effects of Δ9-tetrahydrocannabinol on computational measures of neurocognitive processes are related to recent cannabis use among adolescents and young adults.
Article in Frontiers in adolescent medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preoperative Cannabis Use and Postoperative Delirium in Older Adults Undergoing Major Noncardiac Surgery.Anesthesiology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Cannabis and its main psychoactive constituent, delta-9-tetrahydrocannabinol (THC), are thought to weaken neurocognitive processes. However, past experimental research examining the acute effects of THC on neurocognition has produced mixed results. The current study aims to advance this literature through application of computational modeling and consideration of individual differences in cannabis use history and subjective drug effects. Methods: In a double-blind THC administration experiment, Results: Overall, THC versus placebo did not significantly alter any parameter. However, THC was associated with greater between-person variability in both drift rate and nondecision time, suggesting heterogeneity in the effects of the drug. THC weakened cognitive efficiency (slower drift rates) to a greater extent in participants with less cannabis use. Further, stronger subjective effects (drug "effect" and drug "high") were related to poorer cognitive efficiency during THC intoxication. Discussion: Results add to our understanding of the acute neurocognitive effects of THC. Slower cognitive efficiency after THC was highly heterogeneous, and was related to both recent cannabis use and subjective drug effects. These findings support the notion that acute effects of cannabis on cognitive efficiency (GNG drift rate) are reduced by individuals' tolerance to cannabis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.